Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by jakethesnake2on May 10, 2017 3:37pm
365 Views
Post# 26227659

RE:RE:RE:RE:AGM

RE:RE:RE:RE:AGM
Garth,
I was at the AGM and could not have said it better.
Well done!
One of the last questions asked in French was if Pierre was worried about a hostile takeover at these levels. Seems to me that in the past he always answered that question by saying that Prometic had a poison pill in place that would protect shareholders but unless I misunderstood it seems that he's very concerned about that happenning now. 
Did anyone else get that feeling?
Cheers
Jack
Bullboard Posts